Microchip (MCHP) Director Matthew Chapman Exercises Options for $248K

What Happened Matthew W. Chapman, a director of Microchip Technology Inc. (MCHP), exercised/conversion of derivative instruments on Aug 17, 2026, resulting in the acquisition of 3,090 common shares at an effective cost of $80.26 per share for a total cash outlay of $248,003. The derivative instruments were extinguished in the conversion (no open-market sale of the resulting shares was reported). On Aug 18, 2026 he was also granted 2,557 restricted stock units (RSUs).

Key Details

• Transaction dates and prices:
  • 2026-08-17: Exercise/conversion (code M) — acquired 3,090 shares at $80.26 each; total $248,003.
  • 2026-08-17: Corresponding derivative disposal (code M) — 3,090 derivative units disposed (reported at $0.00) reflecting conversion/exercise.
  • 2026-08-18: Grant/award (code A) — 2,557 RSUs granted (reported at $0.00).
• Shares owned after transaction: Not specified in the provided excerpt of the filing.
• Footnotes:
  • F1: A set of RSUs vested in full on Aug 17, 2026 and vested shares were delivered upon vest.
  • F2: Each RSU represents a contingent right to one share of common stock.
  • F3: The newly reported RSUs will vest in full on Aug 18, 2027 if the recipient remains a service provider; vested shares will be delivered upon vest.
• Filing timeliness: Report filed 2026-08-19 for transactions on 2026-08-17/18 — appears timely under standard two-business-day Form 4 rules.

Context

• The M-code entries indicate an exercise/conversion of derivative instruments (e.g., stock options or other convertible awards); the paired disposal entry at $0.00 typically reflects the extinguishing of the derivative upon conversion, not a sale of shares. No sale of shares in an open market was reported, so this is effectively a purchase/acquisition event plus a new RSU grant.
• The RSU grant vests over a year (Aug 18, 2027) per the footnote and does not represent immediately tradable shares until vesting/delivery.